El Sinemet Genérico se utiliza para tratar los síntomas asociados con la enfermedad de Parkinson y los síntomas parecidos al Parkinson causados por otras enfermedades. Más informaión »
El Sinemet Genérico de Liberación Controlada se utiliza para tratar los síntomas asociados con la enfermedad de Parkinson y los síntomas parecidos al Parkinson causados por otras enfermedades. Más informaión »
Nuestra página de facturación está certificada por:
Orion Sues Mylan In US To Enforce Parkinson's Drug Patents - Fox Business
Orion Sues Mylan In US To Enforce Parkinson's Drug PatentsFox Business-Mylan seeks authorisation to produce and market generic tablets in the United States, with carbidopa, levodopa and entacapone as active ingredients in the same proportion as in Orion's Stalevo.
Orion Group Interim Report January-March 2012 - MarketWatch (press release)
Orion Group Interim Report January-March 2012MarketWatch (press release)On 26 March Orion commented on the ANDA filed by Mylan Pharmaceuticals Inc.
A 64-Year-Old Man With Motor Complications of Advanced Parkinson Disease - Journal of American Medical Association (subscription)
A 64-Year-Old Man With Motor Complications of Advanced Parkinson DiseaseJournal of American Medical Association (subscription)His current medication regimen is carbidopa/levodopa/entacapone 31.
Orion sues Mylan in the US to enforce its US patents covering the proprietary ... - Reuters
Orion sues Mylan in the US to enforce its US patents covering the proprietary .
Orion Sues Mylan In US To Enforce Parkinson's Drug Patents - Capital.gr (press release)
Orion Sues Mylan In US To Enforce Parkinson's Drug PatentsCapital.